News Breaks |
|
|
| September 25, 2012 |
| 11:12 EDT |  | ALNY, NVS | Novartis sells 1.55M shares of Alnylam, still owns 4.05M shares
Alnylam (ALNY) disclosed earlier today that it and Novartis (NVS) entered into a letter agreement pursuant to which the Alnylam agreed that, if during the next five years Novartis is not eligible to sell shares of the company’s common stock it holds, excluding ineligibility resulting from the purchase by Novartis or its affiliates of additional shares of the company’s common stock, Novartis will have registration rights for such shares similar to those rights set forth in the Investor Rights Agreement dated September 6, 2005. The agreement was executed concurrent with the sale by Novartis of 1.55M Alnylam shares, which Alnylam expects will result in the loss of Novartis’ existing demand and piggyback registration rights, as well as its subscription rights, under the Investor Rights Agreement. Following the sale, Novartis reported that it holds 4.05M shares of Alnylam's common stock. |
|
|
News For ALNY;NVS From The Last 14 Days Check below for free stories on ALNY;NVS the last two weeks. |
|
|
| May 22, 2013 |
| 07:28 EDT |  | ALNY | UBS to host a conference
Global Healthcare Services Conference is being held in New York on May 20-22 with webcasted company presentations to begin on May 22 at 8 am; not all company presentations may be webcasted. Webcast Link |
|
| May 21, 2013 |
| 07:44 EDT | | NVS | Sachs Associates to host a forum
 Subscribe for More Information |
|
| 07:24 EDT | | NVS | Global Health Care to host a conference
Subscribe for More Information |
|
| May 20, 2013 |
| 07:29 EDT | | NVS | Deutsche Bank to host a conference
dbAccess Asia Conference 2013 is being held in Singapore on May 20-22. |
|
| May 17, 2013 |
| 16:20 EDT | | NVS | Novartis drug Afinitor extended time without disease progression in women
Subscribe for More Information |
|
| 08:04 EDT | | ALNY | Alnylam announces proof-of-concept data from RNAi program
Subscribe for More Information |
|
| May 16, 2013 |
| 08:11 EDT | | NVS | Novartis says no intention of pursuing Actavis, Bloomberg reports
Subscribe for More Information |
|
| 07:29 EDT | | ALNY | Leerink to host a bus tour
Boston Biopharma Bus Tour travels throughout Boston on May 16-17. |
|
| May 15, 2013 |
| 19:37 EDT |  | NVS | Novartis weighing Actavis bid, WSJ reports
Subscribe for More Information |
|
| 18:17 EDT | | NVS | Novartis weighs possible bid for Actavis, DJ reports
Subscribe for More Information |
| |
| May 14, 2013 |
| 08:43 EDT |  | ALNY | Alnylam has multiple upcoming positive catalysts, says JMP Securities
JMP Securities believes that Alnylam will have multiple positive data catalysts over the next two months. The firm thinks that upcoming data and presentations will enhance the company's positioning and perception of its pipeline, and it keeps an Outperform rating on the shares. |
|
| May 10, 2013 |
| 05:42 EDT | | NVS | Novartis drug Ilaris approved by FDA
Subscribe for More Information |
|
|
|
|
|
